Rice Hall James & Associates LLC Sells 10,696 Shares of Acadia Healthcare Company Inc (ACHC)

Rice Hall James & Associates LLC decreased its holdings in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 2.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 491,992 shares of the company’s stock after selling 10,696 shares during the period. Rice Hall James & Associates LLC’s holdings in Acadia Healthcare were worth $17,318,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Dimensional Fund Advisors LP grew its stake in Acadia Healthcare by 27.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 5,153,977 shares of the company’s stock valued at $210,849,000 after buying an additional 1,122,452 shares in the last quarter. Copper Rock Capital Partners LLC purchased a new position in shares of Acadia Healthcare in the second quarter valued at $27,394,000. BlackRock Inc. grew its position in shares of Acadia Healthcare by 2.1% in the second quarter. BlackRock Inc. now owns 10,336,713 shares of the company’s stock valued at $422,875,000 after purchasing an additional 210,999 shares in the last quarter. State of New Jersey Common Pension Fund D grew its position in shares of Acadia Healthcare by 22.5% in the third quarter. State of New Jersey Common Pension Fund D now owns 980,000 shares of the company’s stock valued at $34,496,000 after purchasing an additional 180,000 shares in the last quarter. Finally, Rothschild Asset Management Inc. grew its position in shares of Acadia Healthcare by 21.9% in the second quarter. Rothschild Asset Management Inc. now owns 961,308 shares of the company’s stock valued at $39,327,000 after purchasing an additional 172,568 shares in the last quarter.

Acadia Healthcare stock opened at $38.58 on Friday. Acadia Healthcare Company Inc has a 52 week low of $26.92 and a 52 week high of $45.02. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.24 and a quick ratio of 1.24. The stock has a market cap of $3.43 billion, a P/E ratio of 16.77, a price-to-earnings-growth ratio of 1.39 and a beta of 0.63.



Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Monday, July 30th. The company reported $0.70 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.70. Acadia Healthcare had a return on equity of 7.93% and a net margin of 7.52%. The company had revenue of $765.70 million during the quarter, compared to analyst estimates of $767.93 million. During the same quarter in the previous year, the firm earned $0.66 earnings per share. Acadia Healthcare’s revenue was up 5.5% on a year-over-year basis. As a group, equities research analysts predict that Acadia Healthcare Company Inc will post 2.52 earnings per share for the current fiscal year.

A number of research analysts have weighed in on the company. Jefferies Financial Group lifted their target price on Acadia Healthcare from $44.00 to $47.00 and gave the company a “buy” rating in a report on Tuesday, July 31st. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $48.00 target price for the company in a report on Tuesday, July 24th. Mizuho set a $37.00 price objective on shares of Acadia Healthcare and gave the company a “hold” rating in a research note on Tuesday, August 28th. Craig Hallum cut shares of Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, October 17th. They noted that the move was a valuation call. Finally, Cantor Fitzgerald reaffirmed a “hold” rating and set a $39.00 price objective on shares of Acadia Healthcare in a research note on Thursday, October 18th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company. Acadia Healthcare currently has a consensus rating of “Hold” and an average target price of $42.90.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.

Featured Article: What does relative strength index mean?

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company Inc (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply